Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Argus Health
Farmers Insurance
Queensland Health
Daiichi Sankyo
Fish and Richardson
US Department of Justice
Healthtrust
Merck
McKinsey

Generated: October 23, 2017

DrugPatentWatch Database Preview

MVC PLUS Drug Profile

« Back to Dashboard

What is the patent landscape for Mvc Plus, and what generic Mvc Plus alternatives are available?

Mvc Plus is a drug marketed by Watson Labs and is included in one NDA.

The generic ingredient in MVC PLUS is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e profile page.

Summary for Tradename: MVC PLUS

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E') AND hsdb_drugname IS N' at line 1
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list56
Clinical Trials: see list9,739